BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 33548198)

  • 1. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response.
    Lin JW; Tang C; Wei HC; Du B; Chen C; Wang M; Zhou Y; Yu MX; Cheng L; Kuivanen S; Ogando NS; Levanov L; Zhao Y; Li CL; Zhou R; Li Z; Zhang Y; Sun K; Wang C; Chen L; Xiao X; Zheng X; Chen SS; Zhou Z; Yang R; Zhang D; Xu M; Song J; Wang D; Li Y; Lei S; Zeng W; Yang Q; He P; Zhang Y; Zhou L; Cao L; Luo F; Liu H; Wang L; Ye F; Zhang M; Li M; Fan W; Li X; Li K; Ke B; Xu J; Yang H; He S; Pan M; Yan Y; Zha Y; Jiang L; Yu C; Liu Y; Xu Z; Li Q; Jiang Y; Sun J; Hong W; Wei H; Lu G; Vapalahti O; Luo Y; Wei Y; Connor T; Tan W; Snijder EJ; Smura T; Li W; Geng J; Ying B; Chen L
    Cell Host Microbe; 2021 Mar; 29(3):489-502.e8. PubMed ID: 33548198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
    Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
    J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Ueno S; Amarbayasgalan S; Sugiura Y; Takahashi T; Shimizu K; Nakagawa K; Kawabata-Iwakawa R; Kamitani W
    Virology; 2024 Jul; 595():110068. PubMed ID: 38593595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
    Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
    J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
    Hayn M; Hirschenberger M; Koepke L; Nchioua R; Straub JH; Klute S; Hunszinger V; Zech F; Prelli Bozzo C; Aftab W; Christensen MH; Conzelmann C; Müller JA; Srinivasachar Badarinarayan S; Stürzel CM; Forne I; Stenger S; Conzelmann KK; Münch J; Schmidt FI; Sauter D; Imhof A; Kirchhoff F; Sparrer KMJ
    Cell Rep; 2021 May; 35(7):109126. PubMed ID: 33974846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
    Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
    PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
    Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines.
    Nakagawa K; Narayanan K; Wada M; Popov VL; Cajimat M; Baric RS; Makino S
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.
    Wathelet MG; Orr M; Frieman MB; Baric RS
    J Virol; 2007 Nov; 81(21):11620-33. PubMed ID: 17715225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.
    Gori Savellini G; Anichini G; Manetti F; Trivisani CI; Cusi MG
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.
    Nemudryi A; Nemudraia A; Wiegand T; Nichols J; Snyder DT; Hedges JF; Cicha C; Lee H; Vanderwood KK; Bimczok D; Jutila MA; Wiedenheft B
    Cell Rep; 2021 Jun; 35(9):109197. PubMed ID: 34043946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of SARS-Cov-2 nonstructural protein 1 polymorphisms found in the Brazilian Amazon.
    Zanchi FB; Mariúba LA; Nascimento V; Souza V; Corado A; Nascimento F; Costa ÁK; Duarte D; Silva G; Mejía M; Pessoa K; Gonçalves L; Brandão MJ; Jesus M; Glória J; Silva M; Mattos T; da Costa C; Naveca FG
    Exp Biol Med (Maywood); 2021 Nov; 246(21):2332-2337. PubMed ID: 34749522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.
    Liu X; Mutso M; Cherkashchenko L; Zusinaite E; Herrero LJ; Doggett SL; Haniotis J; Merits A; Herring BL; Taylor A; Mahalingam S
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.
    Vazquez C; Swanson SE; Negatu SG; Dittmar M; Miller J; Ramage HR; Cherry S; Jurado KA
    PLoS One; 2021; 16(6):e0253089. PubMed ID: 34166398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
    Lopez J; Mommert M; Mouton W; Pizzorno A; Brengel-Pesce K; Mezidi M; Villard M; Lina B; Richard JC; Fassier JB; Cheynet V; Padey B; Duliere V; Julien T; Paul S; Bastard P; Belot A; Bal A; Casanova JL; Rosa-Calatrava M; Morfin F; Walzer T; Trouillet-Assant S
    J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34357402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
    Yuan S; Peng L; Park JJ; Hu Y; Devarkar SC; Dong MB; Shen Q; Wu S; Chen S; Lomakin IB; Xiong Y
    Mol Cell; 2020 Dec; 80(6):1055-1066.e6. PubMed ID: 33188728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.
    Guillen JV; Glaunsinger BA
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2408794121. PubMed ID: 38843251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.